Exponent, Inc. (NASDAQ:EXPO) Director Paul R. Johnston Sells 7,000 Shares

Exponent, Inc. (NASDAQ:EXPO) Director Paul R. Johnston sold 7,000 shares of the company’s stock in a transaction on Monday, June 17th. The shares were sold at an average price of $95.50, for a total transaction of $668,500.00. Following the sale, the director now owns 80,742 shares of the company’s stock, valued at approximately $7,710,861. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.

Exponent Stock Performance

Shares of Exponent stock opened at $96.48 on Wednesday. The firm has a fifty day moving average of $90.67 and a two-hundred day moving average of $85.82. The stock has a market capitalization of $4.89 billion, a price-to-earnings ratio of 48.73 and a beta of 0.65. Exponent, Inc. has a 52 week low of $64.61 and a 52 week high of $102.72.

Exponent (NASDAQ:EXPO) last released its quarterly earnings data on Thursday, April 25th. The business services provider reported $0.59 EPS for the quarter, beating analysts’ consensus estimates of $0.46 by $0.13. Exponent had a net margin of 18.72% and a return on equity of 28.13%. The business had revenue of $137.21 million during the quarter, compared to analysts’ expectations of $125.98 million. During the same quarter in the prior year, the company earned $0.56 EPS. The firm’s quarterly revenue was up 6.6% on a year-over-year basis. As a group, research analysts forecast that Exponent, Inc. will post 1.92 EPS for the current fiscal year.

Exponent Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, June 21st. Investors of record on Friday, June 7th will be given a $0.28 dividend. This represents a $1.12 dividend on an annualized basis and a dividend yield of 1.16%. The ex-dividend date of this dividend is Friday, June 7th. Exponent’s dividend payout ratio is currently 56.57%.

Wall Street Analyst Weigh In

Several analysts have commented on EXPO shares. StockNews.com upgraded shares of Exponent from a “sell” rating to a “hold” rating in a research report on Monday, March 4th. Truist Financial upped their target price on shares of Exponent from $95.00 to $100.00 and gave the company a “buy” rating in a research report on Monday, April 29th.

Institutional Trading of Exponent

A number of large investors have recently made changes to their positions in EXPO. Operose Advisors LLC bought a new stake in shares of Exponent in the 3rd quarter valued at $39,000. Benjamin F. Edwards & Company Inc. boosted its stake in Exponent by 866.0% in the 1st quarter. Benjamin F. Edwards & Company Inc. now owns 512 shares of the business services provider’s stock worth $42,000 after purchasing an additional 459 shares during the period. Janiczek Wealth Management LLC boosted its stake in Exponent by 293.7% in the 1st quarter. Janiczek Wealth Management LLC now owns 626 shares of the business services provider’s stock worth $52,000 after purchasing an additional 467 shares during the period. Principal Securities Inc. acquired a new position in Exponent in the 4th quarter worth $69,000. Finally, YHB Investment Advisors Inc. acquired a new position in Exponent in the 1st quarter worth $75,000. Institutional investors own 92.37% of the company’s stock.

Exponent Company Profile

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.